Promethera Biosciences

Industry

  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy

Other Names/Subsidiaries

  • Baliopharm AG
  • Promethera Biosciences Japan Branch Ltd
See more in Biomedtracker

Latest on Promethera Biosciences

Scrip

Aeglea’s Rare Disease Asset Succeeds At Phase III, In Line To Become First Product

 
• By Ayisha Sharma

Aeglea BioTherapeutics, Inc. ’s pegzilarginase has met the primary endpoint in the Phase III arginase 1 deficiency (ARG1-D) PEACE study, supporting a US filing in the first half of 2022 which could le

Scrip

Asia Deal Watch: Promethera Calls On Hao Tian For Asian JV To Advance Its Liver Candidates

 
• By Ian Haydock, Brian Yang, Vibha Ravi, and Joseph Haas

Promethera Links With Hao Tian On JV For NASH, ACLF, Hepatic Cancer Promethera Biosciences and Hong Kong-based Hao Tian Development Group Ltd. said on 16 July they had entered into an agreement to f

Scrip

Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili

 
• By Ian Haydock, Joseph Haas, Vibha Ravi, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Appili Gains Rights To FUJIF

Scrip

Venture Funding Deals: Takeda's Phathom Raises $140m In Crossover Round For GERD Program

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmace